SeedFolio
Invests early into strong teams developing novel technology to conquer disease or clean the planet, targeting large opportunities with high reward/risk ratios via a rigorous, systematic sourcing and selection process.
Joe Gatto
Managing Director
Founder and former CEO of StarMine, which he grew to $33M ARR (three-time Inc 500 honoree) before selling to Thomson Reuters for $100M. Turned to seed investing afterward, making 45+ investments through SeedFolio Fund 1 before opening Fund 2 to outside investors in 2021, growing assets to $20M. Holds a master's degree from Stanford focused on decision sciences.
Advisory bench includes physicians (dermatology, pulmonology/critical care, psychiatry), a biotech patent attorney, and a genetics PhD. Portfolio exits include RenovoRx (Nasdaq-listed), an acquisition by Intuitive Surgical, and a ~$1B acquisition by Novartis.